recent articles
[SEOUL, South Korea, Jul. 21, 2022] Lunit, a global provider of AI-powered cancer solutions, announced today that it made its stock market debut on the South Korean KOSDAQ under the ticker “A32813”. Lunit’s initial public offering of...
Medical AI software company Fimmic launches aiForward — an open, global program for medical researchers and pathologists willing to experiment with artificial intelligence (AI) in their research. The aiForward program offers its participants...
© 2023 Tissuepathology.com. All rights reserved. Millennial Consulting. | Web Design by Zealth Digital Marketing